NovMetaPharma Co., Ltd. (XKON:229500)
South Korea · Delayed Price · Currency is KRW 5,190.00
+150.00 (2.98%)
At close: Aug 11, 2026
NovMetaPharma Market Cap
NovMetaPharma has a market cap or net worth of 66.65 billion as of August 11, 2026. Its market cap has decreased by -63.21% in one year.
Market Cap
66.65B
Enterprise Value
n/a
Revenue
1.30B
Ranking
n/a
PE Ratio
43.25
Stock Price
5,190.00
ChartMarket Cap Chart
Since April 5, 2017, NovMetaPharma's market cap has decreased from 74.59B to 66.65B, a decrease of -10.65%. That is a compound annual growth rate of -1.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 66.65B | -59.29% |
| Dec 30, 2025 | 163.69B | 187.16% |
| Dec 30, 2024 | 57.00B | -46.33% |
| Dec 29, 2022 | 106.21B | -45.89% |
| Dec 30, 2021 | 196.29B | -9.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ABION | 75.78B |
| BIO-FD&C | 72.17B |
| QuadMedicine | 70.04B |
| PanGen Biotech | 69.87B |
| IMGT Co.,Ltd. | 68.33B |
| AriBioLab | 67.51B |
| KoBioLabs | 64.86B |
| J2KBIO | 61.75B |